nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Megacolon toxic—Methotrexate—psoriatic arthritis	0.073	0.073	CcSEcCtD
Lincomycin—Abdominal distress—Methotrexate—psoriatic arthritis	0.0449	0.0449	CcSEcCtD
Lincomycin—Megacolon—Methotrexate—psoriatic arthritis	0.037	0.037	CcSEcCtD
Lincomycin—Proteinuria—Auranofin—psoriatic arthritis	0.0357	0.0357	CcSEcCtD
Lincomycin—Protein urine present—Auranofin—psoriatic arthritis	0.0352	0.0352	CcSEcCtD
Lincomycin—Glossitis—Auranofin—psoriatic arthritis	0.0341	0.0341	CcSEcCtD
Lincomycin—Aplastic anaemia—Auranofin—psoriatic arthritis	0.0295	0.0295	CcSEcCtD
Lincomycin—Pancytopenia—Auranofin—psoriatic arthritis	0.0187	0.0187	CcSEcCtD
Lincomycin—Neutropenia—Auranofin—psoriatic arthritis	0.0184	0.0184	CcSEcCtD
Lincomycin—Jaundice—Auranofin—psoriatic arthritis	0.0171	0.0171	CcSEcCtD
Lincomycin—Stomatitis—Auranofin—psoriatic arthritis	0.0171	0.0171	CcSEcCtD
Lincomycin—Agranulocytosis—Auranofin—psoriatic arthritis	0.0164	0.0164	CcSEcCtD
Lincomycin—Abscess—Prednisolone—psoriatic arthritis	0.0127	0.0127	CcSEcCtD
Lincomycin—Angioedema—Auranofin—psoriatic arthritis	0.0125	0.0125	CcSEcCtD
Lincomycin—Leukopenia—Auranofin—psoriatic arthritis	0.0123	0.0123	CcSEcCtD
Lincomycin—Abscess—Triamcinolone—psoriatic arthritis	0.0116	0.0116	CcSEcCtD
Lincomycin—Abscess—Methylprednisolone—psoriatic arthritis	0.0116	0.0116	CcSEcCtD
Lincomycin—Azotaemia—Methotrexate—psoriatic arthritis	0.0114	0.0114	CcSEcCtD
Lincomycin—Abscess—Betamethasone—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Lincomycin—Abscess—Dexamethasone—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Lincomycin—Leukocytosis—Methylprednisolone—psoriatic arthritis	0.00978	0.00978	CcSEcCtD
Lincomycin—Abscess—Prednisone—psoriatic arthritis	0.0092	0.0092	CcSEcCtD
Lincomycin—Urticaria—Auranofin—psoriatic arthritis	0.0089	0.0089	CcSEcCtD
Lincomycin—Leukocytosis—Dexamethasone—psoriatic arthritis	0.00889	0.00889	CcSEcCtD
Lincomycin—Leukocytosis—Betamethasone—psoriatic arthritis	0.00889	0.00889	CcSEcCtD
Lincomycin—Abdominal pain—Auranofin—psoriatic arthritis	0.00886	0.00886	CcSEcCtD
Lincomycin—Thrombophlebitis—Prednisolone—psoriatic arthritis	0.0084	0.0084	CcSEcCtD
Lincomycin—Oesophagitis—Methylprednisolone—psoriatic arthritis	0.00839	0.00839	CcSEcCtD
Lincomycin—Pruritus—Auranofin—psoriatic arthritis	0.00793	0.00793	CcSEcCtD
Lincomycin—Leukocytosis—Prednisone—psoriatic arthritis	0.00774	0.00774	CcSEcCtD
Lincomycin—Thrombophlebitis—Triamcinolone—psoriatic arthritis	0.00772	0.00772	CcSEcCtD
Lincomycin—Thrombophlebitis—Methylprednisolone—psoriatic arthritis	0.0077	0.0077	CcSEcCtD
Lincomycin—Abscess—Methotrexate—psoriatic arthritis	0.00768	0.00768	CcSEcCtD
Lincomycin—Diarrhoea—Auranofin—psoriatic arthritis	0.00767	0.00767	CcSEcCtD
Lincomycin—Oesophagitis—Dexamethasone—psoriatic arthritis	0.00763	0.00763	CcSEcCtD
Lincomycin—Oesophagitis—Betamethasone—psoriatic arthritis	0.00763	0.00763	CcSEcCtD
Lincomycin—Dermatitis bullous—Prednisolone—psoriatic arthritis	0.0076	0.0076	CcSEcCtD
Lincomycin—Vomiting—Auranofin—psoriatic arthritis	0.00712	0.00712	CcSEcCtD
Lincomycin—Rash—Auranofin—psoriatic arthritis	0.00706	0.00706	CcSEcCtD
Lincomycin—Dermatitis—Auranofin—psoriatic arthritis	0.00706	0.00706	CcSEcCtD
Lincomycin—Thrombophlebitis—Dexamethasone—psoriatic arthritis	0.00701	0.00701	CcSEcCtD
Lincomycin—Thrombophlebitis—Betamethasone—psoriatic arthritis	0.00701	0.00701	CcSEcCtD
Lincomycin—Dermatitis bullous—Triamcinolone—psoriatic arthritis	0.00699	0.00699	CcSEcCtD
Lincomycin—Proteinuria—Methotrexate—psoriatic arthritis	0.00692	0.00692	CcSEcCtD
Lincomycin—Protein urine present—Methotrexate—psoriatic arthritis	0.00682	0.00682	CcSEcCtD
Lincomycin—Nausea—Auranofin—psoriatic arthritis	0.00665	0.00665	CcSEcCtD
Lincomycin—Oesophagitis—Prednisone—psoriatic arthritis	0.00665	0.00665	CcSEcCtD
Lincomycin—Oliguria—Methotrexate—psoriatic arthritis	0.0066	0.0066	CcSEcCtD
Lincomycin—Glossitis—Methotrexate—psoriatic arthritis	0.0066	0.0066	CcSEcCtD
Lincomycin—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.00635	0.00635	CcSEcCtD
Lincomycin—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.00635	0.00635	CcSEcCtD
Lincomycin—Thrombophlebitis—Prednisone—psoriatic arthritis	0.0061	0.0061	CcSEcCtD
Lincomycin—Vaginal inflammation—Methotrexate—psoriatic arthritis	0.00608	0.00608	CcSEcCtD
Lincomycin—Vaginal infection—Methotrexate—psoriatic arthritis	0.00574	0.00574	CcSEcCtD
Lincomycin—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.00571	0.00571	CcSEcCtD
Lincomycin—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.0051	0.0051	CcSEcCtD
Lincomycin—Neutropenia—Prednisone—psoriatic arthritis	0.00427	0.00427	CcSEcCtD
Lincomycin—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00407	0.00407	CcSEcCtD
Lincomycin—Angioedema—Prednisolone—psoriatic arthritis	0.004	0.004	CcSEcCtD
Lincomycin—Vertigo—Prednisolone—psoriatic arthritis	0.00393	0.00393	CcSEcCtD
Lincomycin—Angioedema—Triamcinolone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Lincomycin—Angioedema—Methylprednisolone—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Lincomycin—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Lincomycin—Pancytopenia—Methotrexate—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Lincomycin—Vertigo—Triamcinolone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Lincomycin—Vertigo—Methylprednisolone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Lincomycin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Lincomycin—Neutropenia—Methotrexate—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Lincomycin—Shock—Prednisolone—psoriatic arthritis	0.00351	0.00351	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Lincomycin—Angioedema—Dexamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Lincomycin—Angioedema—Betamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Lincomycin—Stomatitis—Methotrexate—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Lincomycin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Lincomycin—Vertigo—Dexamethasone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Lincomycin—Vertigo—Betamethasone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Lincomycin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Lincomycin—Shock—Triamcinolone—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Lincomycin—Shock—Methylprednisolone—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Lincomycin—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Lincomycin—Hypotension—Methylprednisolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Lincomycin—Pain—Prednisolone—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Lincomycin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Lincomycin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Lincomycin—Shock—Betamethasone—psoriatic arthritis	0.00293	0.00293	CcSEcCtD
Lincomycin—Shock—Dexamethasone—psoriatic arthritis	0.00293	0.00293	CcSEcCtD
Lincomycin—Angioedema—Prednisone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Lincomycin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Lincomycin—Vertigo—Prednisone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Lincomycin—Tinnitus—Methotrexate—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Lincomycin—Urticaria—Prednisolone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Lincomycin—Pain—Triamcinolone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Lincomycin—Hypotension—Dexamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Lincomycin—Hypotension—Betamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Lincomycin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Lincomycin—Urticaria—Triamcinolone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Lincomycin—Urticaria—Methylprednisolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Lincomycin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Lincomycin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Lincomycin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Lincomycin—Shock—Prednisone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Lincomycin—Pain—Dexamethasone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Lincomycin—Pain—Betamethasone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Lincomycin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Lincomycin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Lincomycin—Vertigo—Methotrexate—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Lincomycin—Leukopenia—Methotrexate—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Lincomycin—Urticaria—Betamethasone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Lincomycin—Urticaria—Dexamethasone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Lincomycin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Lincomycin—Body temperature increased—Betamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Lincomycin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Lincomycin—Abdominal pain—Betamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Lincomycin—Pruritus—Triamcinolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Lincomycin—Pruritus—Methylprednisolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Lincomycin—Rash—Prednisolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Lincomycin—Dermatitis—Prednisolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Lincomycin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Lincomycin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Lincomycin—Nausea—Prednisolone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Lincomycin—Pruritus—Dexamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Lincomycin—Pruritus—Betamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Lincomycin—Vomiting—Triamcinolone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Lincomycin—Vomiting—Methylprednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Lincomycin—Rash—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Lincomycin—Dermatitis—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Lincomycin—Rash—Methylprednisolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Lincomycin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Lincomycin—Urticaria—Prednisone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Lincomycin—Body temperature increased—Prednisone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Lincomycin—Abdominal pain—Prednisone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Lincomycin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Lincomycin—Diarrhoea—Betamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Lincomycin—Hypotension—Methotrexate—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Lincomycin—Nausea—Triamcinolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Lincomycin—Nausea—Methylprednisolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Lincomycin—Hypersensitivity—Prednisone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Lincomycin—Vomiting—Betamethasone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Lincomycin—Vomiting—Dexamethasone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Lincomycin—Rash—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Lincomycin—Rash—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Lincomycin—Dermatitis—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Lincomycin—Dermatitis—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Lincomycin—Pain—Methotrexate—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Lincomycin—Pruritus—Prednisone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Lincomycin—Diarrhoea—Prednisone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Lincomycin—Nausea—Dexamethasone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Lincomycin—Nausea—Betamethasone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Lincomycin—Urticaria—Methotrexate—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Lincomycin—Abdominal pain—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Lincomycin—Body temperature increased—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Lincomycin—Vomiting—Prednisone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Lincomycin—Rash—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Lincomycin—Dermatitis—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Lincomycin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Lincomycin—Nausea—Prednisone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Lincomycin—Pruritus—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Lincomycin—Diarrhoea—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Lincomycin—Vomiting—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Lincomycin—Rash—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Lincomycin—Dermatitis—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Lincomycin—Nausea—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
